These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31465324)

  • 21. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections.
    Seaton RA; Sharp E; Bezlyak V; Weir CJ
    Int J Antimicrob Agents; 2011 Sep; 38(3):243-8. PubMed ID: 21741221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infectious Diseases Specialty Intervention Is Associated With Better Outcomes Among Privately Insured Individuals Receiving Outpatient Parenteral Antimicrobial Therapy.
    Shah A; Petrak R; Fliegelman R; Shrestha N; Allison G; Zurlo J; Parker S; Poretz D; McKinsey D; Dougherty M; Martinelli L; Mathur A; Rodriguez A; Smith MW
    Clin Infect Dis; 2019 Mar; 68(7):1160-1165. PubMed ID: 30247512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people.
    Mujal A; Sola J; Hernandez M; Villarino MA; Baylina M; Tajan J; Oristrell J
    J Antimicrob Chemother; 2016 May; 71(5):1402-7. PubMed ID: 26832749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children's hospital.
    Madigan T; Banerjee R
    Pediatr Infect Dis J; 2013 Apr; 32(4):346-9. PubMed ID: 23249915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.
    Mackintosh CL; White HA; Seaton RA
    J Antimicrob Chemother; 2011 Feb; 66(2):408-15. PubMed ID: 21118914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.
    Huck D; Ginsberg JP; Gordon SM; Nowacki AS; Rehm SJ; Shrestha NK
    J Antimicrob Chemother; 2014 Jan; 69(1):228-33. PubMed ID: 23887864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.
    Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG
    Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital.
    Upton A; Ellis-Pegler RB; Woodhouse A
    N Z Med J; 2004 Aug; 117(1200):U1020. PubMed ID: 15475990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and clinical outcomes of outpatient parenteral antibiotic therapy for infective endocarditis in Christchurch, New Zealand: A retrospective cohort study.
    Campbell PO; Gallagher K; Dalton SC; Metcalf SCL; Douglas NM; Chambers ST
    Int J Infect Dis; 2023 Sep; 134():172-176. PubMed ID: 37331565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
    Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
    Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting.
    White HA; Davis JS; Kittler P; Currie BJ
    Intern Med J; 2011 Sep; 41(9):668-73. PubMed ID: 20002854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A qualitative study of patients' feedback about Outpatient Parenteral Antimicrobial Therapy (OPAT) services in Northern England: implications for service improvement.
    Twiddy M; Czoski Murray CJ; Mason SJ; Meads D; Wright JM; Mitchell ED; Minton J;
    BMJ Open; 2018 Jan; 8(1):e019099. PubMed ID: 29326190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.
    Barr DA; Semple L; Seaton RA
    Int J Antimicrob Agents; 2012 May; 39(5):407-13. PubMed ID: 22445493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outpatient parenteral antimicrobial therapy (OPAT) in the UK: a cross-sectional survey of acute hospital trusts and health boards.
    Durojaiye OC; Cartwright K; Ntziora F
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):58-62. PubMed ID: 30098851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of Outpatient Parenteral Antimicrobial Therapy in Children.
    Fernandes P; Milliren C; Mahoney-West HM; Schwartz L; Lachenauer CS; Nakamura MM
    Pediatr Infect Dis J; 2018 Feb; 37(2):157-163. PubMed ID: 28763427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
    Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of expanding a paediatric OPAT programme with an antimicrobial stewardship intervention.
    Huynh J; Hodgson KA; Boyce S; Ibrahim LF; Bryant PA
    Arch Dis Child; 2020 Dec; 105(12):1220-1228. PubMed ID: 32381516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone.
    Seaton RA; Bell E; Gourlay Y; Semple L
    J Antimicrob Chemother; 2005 May; 55(5):764-7. PubMed ID: 15772137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.